College of Medicine Celebrates 13 Nationally Recognized Medical Professors

On Wednesday, Jan. 6, the University of Cincinnati College of Medicine faculty and staff celebrated 13 medical professors who have been nationally recognized for being among the top 10 percent in their field. The event was hosted by William Ball, MD, College of Medicine dean and senior vice president for health affairs. 

The following 13 UC College of Medicine professors received the Patient Experience Excellence Award:

  • Michael Canos, MD – Internal Medicine
  • Stephen Dailey, MD – Orthopaedic Surgery 
  • Andrew Duker, MD – Neurology and Rehabilitation Medicine 
  • Hugh Gloster, MD – Dermatology
  • Adam Ingraffea, MD – Dermatology 
  • Michael Holliday, MD – Family and Community Medicine  
  • Bradley Mathis, MD – Internal Medicine
  • Caroline Mueller, MD – Internal Medicine
  • Sona Sharma, MD – Internal Medicine
  • Barbara Vinegar, DPM – Surgery 
  • Abid Yaqub, MD – Internal Medicine
  • Nadia Yaqub, MD – Internal Medicine
  • Lee Zimmer, MD, PhD – Otolaryngology-Head and Neck Surgery

The faculty members were selected for being among the top 10 percent of clinical providers in the Press Ganey national database. Press Ganey provides patient experience measurement and performance analytics for more than 22,000 health care facilities.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.